Recent research highlights five potential biomarkers—INHBA, MMP7, PSAT1, SLC7A5, and TGFBI—with elevated levels in colorectal cancer tissues and serum of patients, showing promise for non‐invasive CRC detection. Here, PSAT1 is linked to colorectal carcinoma.